Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Merck Millipore Live Lab Tour 2012 to Visit Science Zones in Europe

Published: Monday, April 23, 2012
Last Updated: Monday, April 23, 2012
Bookmark and Share
The “Live Lab Tour” will be ready to roll on 15 May. This innovative concept brings latest Merck Millipore technologies to the workplace, with one-to-one planned meetings available at each site.

Merck Millipore, the Life Science division of Merck KGaA, Darmstadt, Germany has announced the schedule for the Merck Millipore Live Lab Tour 2012 that will visit nine science parks and institutions in Europe starting in May.

The “Live Lab,” a 60-square-meter exhibition space housed in an eye-catching coach-style vehicle, is aLLT-visual-(3).gif novel way to bring information about new technologies right to the workplace. Keltoum Benchikh, Lab Water Head of Global Marketing-Communications, explains that the Live Lab Tour concept is part of a portfolio of marketing communications tools designed to present product information in the easiest, most accessible manner possible. “Live Lab visitors will discover our product offering in situ, and will get actual hands-on experience working with Merck Millipore equipment and other materials,” she says. “In addition, Merck Millipore experts will be present at each site to discuss best practices that will help visitors optimize protocols and improve their laboratory work flows,” she adds.

Three laboratories will be set up within the vehicle: a pharmaceutical lab, an academic research lab, and a food and beverages lab. All will be equipped with the Merck Millipore solutions required to perform actual experiments.

For visitors who would like to discuss their specific situations in more detail, special one-to-one sessions with Merck Millipore experts are available at each site from 10:00 am to 3:30 pm every day.

Schedule: Merck Millipore Live Lab Tour 2012
UK – London: 15 May, University College London
UK – London: 16 May, Imperial College
UK – Oxford: 17 May, Milton Science Park
UK – Newcastle: 21 May, Centre for Life
NL – Utrecht: 24 May, Universiteit Utrecht
BE – Liège: 29 May, Université de Liège
FR – Molsheim: 31 May, Merck Millipore
IT – Milan: 5 June, INFN (Italian National Institute of Nuclear Physics)

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Merck Millipore Announces Incoming CEO and President
Udit Batra, Ph.D. will be responsible for the organization’s strategic direction to drive growth and product innovation as well as oversight of the worldwide operations.
Tuesday, April 15, 2014
Merck KGaA Passes EXCiPACT Audit for Certification as Provider of Pharmaceutical Excipients
Ensures current GMP and GDP requirements applied to pharmaceutical excipients through a recognized auditing and certification process.
Friday, August 02, 2013
Scientific News
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
New Test Detects All Viruses
A new test detects virtually any virus that infects people and animals, according to research at Washington University School of Medicine in St. Louis, where the technology was developed.
Scientists Create World’s Largest Catalog of Human Genomic Variation
An international team of scientists from the 1000 Genomes Project Consortium has created the world’s largest catalog of genomic differences among humans, providing researchers with powerful clues to help them establish why some people are susceptible to various diseases.
Chip-Based Technology Enables Reliable Direct Detection of Ebola Virus
Hybrid device integrates a microfluidic chip for sample preparation and an optofluidic chip for optical detection of individual molecules of viral RNA.
Diagnostics Breakthrough Brings Viral Sequencing to Doctors’ Toolkit
New screening tool produces up to 10,000-fold improvement in viral matches compared with traditional high-throughput methods.
New Cell Type May Help Explain Dangerous Food Allergies
Researchers have discovered a new cell type that appears to drive life-threatening food allergies and may help explain why some people get severe allergic reactions and others do not.
Molecular Diagnostics At Home
Electrochemical test's sensing principle may be generalized to many different targets, leading to inexpensive devices that could detect dozens of disease markers in less than 5 minutes.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos